APO Research
Talk to an analyst

APO RESEARCH · REPORT

Penpulimab Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Penpulimab Injection Market Analysis and Forecast 2026-2032

27 December 2025191 pages

Choose your research edition.

Industry ResearchPenpulimab Injection Industry Research Report 2026107 pages · $2,950 USDIndustry Growth & TrendsGlobal Penpulimab Injection Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Penpulimab Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Penpulimab Injection Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Penpulimab Injection Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Penpulimab Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Penpulimab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Penpulimab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Penpulimab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Penpulimab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Penpulimab Injection include Akeso, Inc. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Penpulimab Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Penpulimab Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Penpulimab Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Penpulimab Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Penpulimab Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Penpulimab Injection sales, projected growth trends, production technology, application and end-user industry.

Penpulimab Injection Segment by Company

Akeso, Inc

Penpulimab Injection Segment by Type

100mg (10mL)/Bottle

Other

Penpulimab Injection Segment by Application

Lymphoma

Liver Cancer

Lung Cancer

Nasopharyngeal Carcinoma

Gastric Cancer

Penpulimab Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Penpulimab Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Penpulimab Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Penpulimab Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Penpulimab Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Penpulimab Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Penpulimab Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Penpulimab Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 100mg (10mL)/Bottle Major Manufacturers Table 3. Other Major Manufacturers Table 4. Global Penpulimab Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Lymphoma Major Manufacturers Table 6. Liver Cancer Major Manufacturers Table 7. Lung Cancer Major Manufacturers Table 8. Nasopharyngeal Carcinoma Major Manufacturers Table 9. Gastric Cancer Major Manufacturers Table 10. Penpulimab Injection Industry Trends Table 11. Penpulimab Injection Industry Drivers Table 12. Penpulimab Injection Industry Opportunities and Challenges Table 13. Penpulimab Injection Industry Restraints Table 14. Global Penpulimab Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Penpulimab Injection Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Penpulimab Injection Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Penpulimab Injection Revenue Market Share by Region (2021-2026) Table 18. Global Penpulimab Injection Revenue Market Share by Region (2027-2032) Table 19. Global Penpulimab Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Penpulimab Injection Sales by Region (2021-2026) & (K Units) Table 21. Global Penpulimab Injection Sales by Region (2027-2032) & (K Units) Table 22. Global Penpulimab Injection Sales Market Share by Region (2021-2026) Table 23. Global Penpulimab Injection Sales Market Share by Region (2027-2032) Table 24. Global Penpulimab Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Penpulimab Injection Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Penpulimab Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Penpulimab Injection Sales Market Share by Manufacturers (2021-2026) Table 28. Global Penpulimab Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Penpulimab Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Penpulimab Injection Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Penpulimab Injection Manufacturers, Product Type & Application Table 32. Global Penpulimab Injection Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Penpulimab Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Penpulimab Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Penpulimab Injection Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Penpulimab Injection Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Penpulimab Injection Revenue Market Share by Type (2021-2026) Table 39. Global Penpulimab Injection Revenue Market Share by Type (2027-2032) Table 40. Global Penpulimab Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Penpulimab Injection Sales by Type (2021-2026) & (K Units) Table 42. Global Penpulimab Injection Sales by Type (2027-2032) & (K Units) Table 43. Global Penpulimab Injection Sales Market Share by Type (2021-2026) Table 44. Global Penpulimab Injection Sales Market Share by Type (2027-2032) Table 45. Global Penpulimab Injection Price by Type (2021-2026) & (US$/Unit) Table 46. Global Penpulimab Injection Price by Type (2027-2032) & (US$/Unit) Table 47. Global Penpulimab Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Penpulimab Injection Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Penpulimab Injection Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Penpulimab Injection Revenue Market Share by Application (2021-2026) Table 51. Global Penpulimab Injection Revenue Market Share by Application (2027-2032) Table 52. Global Penpulimab Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Penpulimab Injection Sales by Application (2021-2026) & (K Units) Table 54. Global Penpulimab Injection Sales by Application (2027-2032) & (K Units) Table 55. Global Penpulimab Injection Sales Market Share by Application (2021-2026) Table 56. Global Penpulimab Injection Sales Market Share by Application (2027-2032) Table 57. Global Penpulimab Injection Price by Application (2021-2026) & (US$/Unit) Table 58. Global Penpulimab Injection Price by Application (2027-2032) & (US$/Unit) Table 59. Akeso, Inc Company Information Table 60. Akeso, Inc Business Overview Table 61. Akeso, Inc Penpulimab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Akeso, Inc Penpulimab Injection Product Portfolio Table 63. Akeso, Inc Recent Development Table 64. North America Penpulimab Injection Revenue by Type (2021-2026) & (US$ Million) Table 65. North America Penpulimab Injection Revenue by Type (2027-2032) & (US$ Million) Table 66. North America Penpulimab Injection Sales by Type (2021-2026) & (K Units) Table 67. North America Penpulimab Injection Sales by Type (2027-2032) & (K Units) Table 68. North America Penpulimab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 69. North America Penpulimab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 70. North America Penpulimab Injection Revenue by Application (2021-2026) & (US$ Million) Table 71. North America Penpulimab Injection Revenue by Application (2027-2032) & (US$ Million) Table 72. North America Penpulimab Injection Sales by Application (2021-2026) & (K Units) Table 73. North America Penpulimab Injection Sales by Application (2027-2032) & (K Units) Table 74. North America Penpulimab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 75. North America Penpulimab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 76. North America Penpulimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 77. North America Penpulimab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 78. North America Penpulimab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 79. North America Penpulimab Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 80. North America Penpulimab Injection Sales by Country (2021-2026) & (K Units) Table 81. North America Penpulimab Injection Sales by Country (2027-2032) & (K Units) Table 82. North America Penpulimab Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 83. North America Penpulimab Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 84. United States Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 85. Canada Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 86. Mexico Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 87. Europe Penpulimab Injection Revenue by Type (2021-2026) & (US$ Million) Table 88. Europe Penpulimab Injection Revenue by Type (2027-2032) & (US$ Million) Table 89. Europe Penpulimab Injection Sales by Type (2021-2026) & (K Units) Table 90. Europe Penpulimab Injection Sales by Type (2027-2032) & (K Units) Table 91. Europe Penpulimab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 92. Europe Penpulimab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 93. Europe Penpulimab Injection Revenue by Application (2021-2026) & (US$ Million) Table 94. Europe Penpulimab Injection Revenue by Application (2027-2032) & (US$ Million) Table 95. Europe Penpulimab Injection Sales by Application (2021-2026) & (K Units) Table 96. Europe Penpulimab Injection Sales by Application (2027-2032) & (K Units) Table 97. Europe Penpulimab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 98. Europe Penpulimab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 99. Europe Penpulimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. Europe Penpulimab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 101. Europe Penpulimab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 102. Europe Penpulimab Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 103. Europe Penpulimab Injection Sales by Country (2021-2026) & (K Units) Table 104. Europe Penpulimab Injection Sales by Country (2027-2032) & (K Units) Table 105. Europe Penpulimab Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 106. Europe Penpulimab Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 107. Germany Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 108. France Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 109. U.K. Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 110. Italy Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 111. Russia Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 112. Spain Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 113. Netherlands Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 114. Switzerland Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 115. Sweden Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 116. Poland Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 117. China Penpulimab Injection Revenue by Type (2021-2026) & (US$ Million) Table 118. China Penpulimab Injection Revenue by Type (2027-2032) & (US$ Million) Table 119. China Penpulimab Injection Sales by Type (2021-2026) & (K Units) Table 120. China Penpulimab Injection Sales by Type (2027-2032) & (K Units) Table 121. China Penpulimab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 122. China Penpulimab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 123. China Penpulimab Injection Revenue by Application (2021-2026) & (US$ Million) Table 124. China Penpulimab Injection Revenue by Application (2027-2032) & (US$ Million) Table 125. China Penpulimab Injection Sales by Application (2021-2026) & (K Units) Table 126. China Penpulimab Injection Sales by Application (2027-2032) & (K Units) Table 127. China Penpulimab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 128. China Penpulimab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 129. Asia Penpulimab Injection Revenue by Type (2021-2026) & (US$ Million) Table 130. Asia Penpulimab Injection Revenue by Type (2027-2032) & (US$ Million) Table 131. Asia Penpulimab Injection Sales by Type (2021-2026) & (K Units) Table 132. Asia Penpulimab Injection Sales by Type (2027-2032) & (K Units) Table 133. Asia Penpulimab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 134. Asia Penpulimab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 135. Asia Penpulimab Injection Revenue by Application (2021-2026) & (US$ Million) Table 136. Asia Penpulimab Injection Revenue by Application (2027-2032) & (US$ Million) Table 137. Asia Penpulimab Injection Sales by Application (2021-2026) & (K Units) Table 138. Asia Penpulimab Injection Sales by Application (2027-2032) & (K Units) Table 139. Asia Penpulimab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 140. Asia Penpulimab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 141. Asia Penpulimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Asia Penpulimab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 143. Asia Penpulimab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 144. Asia Penpulimab Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 145. Asia Penpulimab Injection Sales by Country (2021-2026) & (K Units) Table 146. Asia Penpulimab Injection Sales by Country (2027-2032) & (K Units) Table 147. Asia Penpulimab Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 148. Asia Penpulimab Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 149. Japan Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 150. South Korea Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 151. India Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 152. Australia Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 153. Taiwan Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 154. Southeast Asia Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 155. SAMEA Penpulimab Injection Revenue by Type (2021-2026) & (US$ Million) Table 156. SAMEA Penpulimab Injection Revenue by Type (2027-2032) & (US$ Million) Table 157. SAMEA Penpulimab Injection Sales by Type (2021-2026) & (K Units) Table 158. SAMEA Penpulimab Injection Sales by Type (2027-2032) & (K Units) Table 159. SAMEA Penpulimab Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 160. SAMEA Penpulimab Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 161. SAMEA Penpulimab Injection Revenue by Application (2021-2026) & (US$ Million) Table 162. SAMEA Penpulimab Injection Revenue by Application (2027-2032) & (US$ Million) Table 163. SAMEA Penpulimab Injection Sales by Application (2021-2026) & (K Units) Table 164. SAMEA Penpulimab Injection Sales by Application (2027-2032) & (K Units) Table 165. SAMEA Penpulimab Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 166. SAMEA Penpulimab Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 167. SAMEA Penpulimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. SAMEA Penpulimab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 169. SAMEA Penpulimab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 170. SAMEA Penpulimab Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 171. SAMEA Penpulimab Injection Sales by Country (2021-2026) & (K Units) Table 172. SAMEA Penpulimab Injection Sales by Country (2027-2032) & (K Units) Table 173. SAMEA Penpulimab Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 174. SAMEA Penpulimab Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 175. Brazil Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 176. Argentina Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 177. Chile Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 178. Colombia Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 179. Peru Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 180. Saudi Arabia Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 181. Israel Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 182. UAE Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 183. Turkey Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 184. Iran Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 185. Egypt Penpulimab Injection Revenue (2021-2032) & (US$ Million) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Penpulimab Injection Distributors List Table 189. Penpulimab Injection Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Penpulimab Injection Image Figure 2. Global Penpulimab Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Penpulimab Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 100mg (10mL)/Bottle Image Figure 5. Other Image Figure 6. Global Penpulimab Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Penpulimab Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Lymphoma Image Figure 9. Liver Cancer Image Figure 10. Lung Cancer Image Figure 11. Nasopharyngeal Carcinoma Image Figure 12. Gastric Cancer Image Figure 13. Global Penpulimab Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Penpulimab Injection Revenue (2021-2032) & (US$ Million) Figure 15. Global Penpulimab Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Penpulimab Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Penpulimab Injection Revenue Market Share by Region (2021-2032) Figure 18. Global Penpulimab Injection Sales (2021-2032) & (K Units) Figure 19. Global Penpulimab Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Penpulimab Injection Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Penpulimab Injection Sales YoY (2021-2032) & (K Units) Figure 22. Europe Penpulimab Injection Sales YoY (2021-2032) & (K Units) Figure 23. China Penpulimab Injection Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Penpulimab Injection Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Penpulimab Injection Sales YoY (2021-2032) & (K Units) Figure 26. Global Penpulimab Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Penpulimab Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Penpulimab Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Penpulimab Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Penpulimab Injection Revenue Market Share by Type (2021-2032) Figure 32. Global Penpulimab Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Penpulimab Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Penpulimab Injection Sales Market Share by Type (2021-2032) Figure 35. Global Penpulimab Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Penpulimab Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Penpulimab Injection Revenue Market Share by Application (2021-2032) Figure 38. Global Penpulimab Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Penpulimab Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Penpulimab Injection Sales Market Share by Application (2021-2032) Figure 41. North America Penpulimab Injection Revenue Share by Type (2021-2032) Figure 42. North America Penpulimab Injection Sales Share by Type (2021-2032) Figure 43. North America Penpulimab Injection Revenue Share by Application (2021-2032) Figure 44. North America Penpulimab Injection Sales Share by Application (2021-2032) Figure 45. North America Penpulimab Injection Revenue Share by Country (2021-2032) Figure 46. North America Penpulimab Injection Sales Share by Country (2021-2032) Figure 47. Europe Penpulimab Injection Revenue Share by Type (2021-2032) Figure 48. Europe Penpulimab Injection Sales Share by Type (2021-2032) Figure 49. Europe Penpulimab Injection Revenue Share by Application (2021-2032) Figure 50. Europe Penpulimab Injection Sales Share by Application (2021-2032) Figure 51. Europe Penpulimab Injection Revenue Share by Country (2021-2032) Figure 52. Europe Penpulimab Injection Sales Share by Country (2021-2032) Figure 53. China Penpulimab Injection Revenue Share by Type (2021-2032) Figure 54. China Penpulimab Injection Sales Share by Type (2021-2032) Figure 55. China Penpulimab Injection Revenue Share by Application (2021-2032) Figure 56. China Penpulimab Injection Sales Share by Application (2021-2032) Figure 57. Asia Penpulimab Injection Revenue Share by Type (2021-2032) Figure 58. Asia Penpulimab Injection Sales Share by Type (2021-2032) Figure 59. Asia Penpulimab Injection Revenue Share by Application (2021-2032) Figure 60. Asia Penpulimab Injection Sales Share by Application (2021-2032) Figure 61. Asia Penpulimab Injection Revenue Share by Country (2021-2032) Figure 62. Asia Penpulimab Injection Sales Share by Country (2021-2032) Figure 63. SAMEA Penpulimab Injection Revenue Share by Type (2021-2032) Figure 64. SAMEA Penpulimab Injection Sales Share by Type (2021-2032) Figure 65. SAMEA Penpulimab Injection Revenue Share by Application (2021-2032) Figure 66. SAMEA Penpulimab Injection Sales Share by Application (2021-2032) Figure 67. SAMEA Penpulimab Injection Revenue Share by Country (2021-2032) Figure 68. SAMEA Penpulimab Injection Sales Share by Country (2021-2032) Figure 69. Penpulimab Injection Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Penpulimab Injection Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg (10mL)/Bottle
  • Other
Applications
  • Lymphoma
  • Liver Cancer
  • Lung Cancer
  • Nasopharyngeal Carcinoma
  • Gastric Cancer
Companies covered
  • Akeso, Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Penpulimab Injection Market by Type
  3. 1.2.1 Global Penpulimab Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 100mg (10mL)/Bottle
  5. 1.2.3 Other
  6. 1.3 Penpulimab Injection Market by Application
  7. 1.3.1 Global Penpulimab Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Lymphoma
  9. 1.3.3 Liver Cancer
  10. 1.3.4 Lung Cancer
  11. 1.3.5 Nasopharyngeal Carcinoma
  12. 1.3.6 Gastric Cancer
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Penpulimab Injection Market Dynamics
  1. 2.1 Penpulimab Injection Industry Trends
  2. 2.2 Penpulimab Injection Industry Drivers
  3. 2.3 Penpulimab Injection Industry Opportunities and Challenges
  4. 2.4 Penpulimab Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Penpulimab Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Penpulimab Injection Revenue by Region
  3. 3.2.1 Global Penpulimab Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Penpulimab Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Penpulimab Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Penpulimab Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Penpulimab Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Penpulimab Injection Sales by Region
  9. 3.4.1 Global Penpulimab Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Penpulimab Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Penpulimab Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Penpulimab Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Penpulimab Injection Revenue by Manufacturers
  2. 4.1.1 Global Penpulimab Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Penpulimab Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Penpulimab Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Penpulimab Injection Sales by Manufacturers
  6. 4.2.1 Global Penpulimab Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Penpulimab Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Penpulimab Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Penpulimab Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Penpulimab Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Penpulimab Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Penpulimab Injection Manufacturers, Product Type & Application
  13. 4.7 Global Penpulimab Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Penpulimab Injection Market CR5 and HHI
  16. 4.8.2 2025 Penpulimab Injection Tier 1, Tier 2, and Tier 3
5 Penpulimab Injection Market by Type
  1. 5.1 Global Penpulimab Injection Revenue by Type
  2. 5.1.1 Global Penpulimab Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Penpulimab Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Penpulimab Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Penpulimab Injection Sales by Type
  6. 5.2.1 Global Penpulimab Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Penpulimab Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Penpulimab Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Penpulimab Injection Price by Type
6 Penpulimab Injection Market by Application
  1. 6.1 Global Penpulimab Injection Revenue by Application
  2. 6.1.1 Global Penpulimab Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Penpulimab Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Penpulimab Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Penpulimab Injection Sales by Application
  6. 6.2.1 Global Penpulimab Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Penpulimab Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Penpulimab Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Penpulimab Injection Price by Application
7 Company Profiles
  1. 7.1 Akeso, Inc
  2. 7.1.1 Akeso, Inc Company Information
  3. 7.1.2 Akeso, Inc Business Overview
  4. 7.1.3 Akeso, Inc Penpulimab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Akeso, Inc Penpulimab Injection Product Portfolio
  6. 7.1.5 Akeso, Inc Recent Developments
8 North America
  1. 8.1 North America Penpulimab Injection Market Size by Type
  2. 8.1.1 North America Penpulimab Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Penpulimab Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Penpulimab Injection Price by Type (2021-2032)
  5. 8.2 North America Penpulimab Injection Market Size by Application
  6. 8.2.1 North America Penpulimab Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Penpulimab Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Penpulimab Injection Price by Application (2021-2032)
  9. 8.3 North America Penpulimab Injection Market Size by Country
  10. 8.3.1 North America Penpulimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Penpulimab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Penpulimab Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Penpulimab Injection Market Size by Type
  2. 9.1.1 Europe Penpulimab Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Penpulimab Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Penpulimab Injection Price by Type (2021-2032)
  5. 9.2 Europe Penpulimab Injection Market Size by Application
  6. 9.2.1 Europe Penpulimab Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Penpulimab Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Penpulimab Injection Price by Application (2021-2032)
  9. 9.3 Europe Penpulimab Injection Market Size by Country
  10. 9.3.1 Europe Penpulimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Penpulimab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Penpulimab Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Penpulimab Injection Market Size by Type
  2. 10.1.1 China Penpulimab Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Penpulimab Injection Sales by Type (2021-2032)
  4. 10.1.3 China Penpulimab Injection Price by Type (2021-2032)
  5. 10.2 China Penpulimab Injection Market Size by Application
  6. 10.2.1 China Penpulimab Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Penpulimab Injection Sales by Application (2021-2032)
  8. 10.2.3 China Penpulimab Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Penpulimab Injection Market Size by Type
  2. 11.1.1 Asia Penpulimab Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Penpulimab Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Penpulimab Injection Price by Type (2021-2032)
  5. 11.2 Asia Penpulimab Injection Market Size by Application
  6. 11.2.1 Asia Penpulimab Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Penpulimab Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Penpulimab Injection Price by Application (2021-2032)
  9. 11.3 Asia Penpulimab Injection Market Size by Country
  10. 11.3.1 Asia Penpulimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Penpulimab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Penpulimab Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Penpulimab Injection Market Size by Type
  2. 12.1.1 SAMEA Penpulimab Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Penpulimab Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Penpulimab Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Penpulimab Injection Market Size by Application
  6. 12.2.1 SAMEA Penpulimab Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Penpulimab Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Penpulimab Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Penpulimab Injection Market Size by Country
  10. 12.3.1 SAMEA Penpulimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Penpulimab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Penpulimab Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Penpulimab Injection Value Chain Analysis
  2. 13.1.1 Penpulimab Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Penpulimab Injection Production Mode & Process
  6. 13.2 Penpulimab Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Penpulimab Injection Distributors
  9. 13.2.3 Penpulimab Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst